Enhancing Patient Safety Through Prescription Drug Monitoring Programs

This white paper discusses the role of Prescription Drug Monitoring Programs (PDMPs) in improving patient safety and outcomes in the context of the opioid epidemic. PDMPs serve as essential tools for clinicians by providing timely data on controlled substance prescriptions, which helps identify patients at risk for substance use disorders. The paper outlines the evolution of PDMPs, highlighting their integration into clinical workflows and the importance of real-time data sharing among healthcare providers. It details three key benefits of comprehensive PDMP utilization: expanded data sets that include nonfatal overdoses, integration of multi-state PDMP data into electronic health records (EHRs), and proactive decision support for clinicians. Additionally, the paper presents innovative strategies aimed at enhancing PDMP effectiveness, including Medication for Opioid Use Disorder (MOUD) prompts and Naloxone administration indicators. These advancements aim to support better patient care and public health initiatives by enabling informed decision-making and timely interventions.